locator iconlocator icon
All Labs
 
add to cart

Glycosylated Hemoglobin (HbA1c)

450
4.1
NABL, CAP, ISO
ADD TO CART
Overview
Interpretations
FAQ's
Glycosylated Hemoglobin (HbA1c)

Overview of Glycosylated Hemoglobin (HbA1c)

What is Glycosylated Hemoglobin (HbA1c)?

Glycosylated Hemoglobin, also called Glycated Hemoglobin, Hemoglobin A1c, or HbA1c, refers to hemoglobin which is bound to glucose. Glycosylated Hemoglobin Test is performed to measure the percentage of glycosylated hemoglobin in blood which reflects the average blood glucose over a period of past two to three months (8 - 12 weeks).

Sample Type

The sample type collected for Glycosylated Hemoglobin (HbA1c) is: Blood

Preparation for Glycosylated Hemoglobin (HbA1c)

  • No special preparation required

Why Get Tested for Glycosylated Hemoglobin (HbA1c)?

The Glycosylated Hemoglobin test is performed to:

  • Monitor Diabetes treatment efficacy by measuring glycosylated hemoglobin regularly 

  • Screen for Diabetes as part of regular health checkup, as well as in patients with high risk of developing diabetes

  • Diagnose and confirm diabetes in combination with other tests if blood sugar levels are high over a long period of time


        

Understand more about Glycosylated Hemoglobin (HbA1c)

Hemoglobin is the protein found in Red Blood Cells and is responsible for transporting oxygen. Of the different types of hemoglobin, Hemoglobin A is predominant. With elevation of blood sugar levels, some glucose binds spontaneously to Hemoglobin A (this binding is called Glycosylation or Glycation) and remains bound for the complete lifetime of the RBC, which is 120 days normally. Higher the level of glucose in the blood, greater is the amount of it binding to Hemoglobin A. Hemoglobin A1c is the dominant form of Glycated Hemoglobin. As RBCs die and are replaced, Hemoglobin A1c is cleared and slowly replaced with non-glycosylated hemoglobin. Measurement of HbA1c level over a period of time gives an indication of the level of glucose in the blood over the specified period of time. This helps in the diagnosis of Diabetes and is useful for monitoring the effectiveness of measures taken to reduce blood sugar levels.


What Results of Glycosylated Hemoglobin (HbA1c) mean?

Interpretations

Normal: Below 5.7% (39 mmol/mol approx.)

Prediabetic: 5.7% - 6.4% (39 to 46 mmol/mol approx.)

Diabetic: Above 6.5% (above 48 mmol/mol approx.)


Less than 5.7% Glycated Hemoglobin indicates normal levels of blood sugar. Increased risk of developing Diabetes is found in Prediabetic patients with blood sugar level between 5.7% and 6.4%. Patients with a HbA1c level greater than 6.5% are usually diagnosed with Diabetes.


Patient Concerns about Glycosylated Hemoglobin (HbA1c)

Frequently Asked Questions about Glycosylated Hemoglobin (HbA1c)

Q. How is this test performed?
This test is performed on a blood sample. A syringe with a fine needle attached is used to withdraw blood sample from a blood vessel in your arm generally from the inner side of the elbow area. The doctor, nurse or the phlebotomist will tie an elastic band around your arm which will help the blood vessels to swell with blood and hence makes it easier to withdraw blood. You may be asked to tightly clench your fist. Once the veins are clearly visible, the area is cleaned with an antiseptic solution and then the needle is inserted into the blood vessel to collect the sample. You may feel a tiny pinprick during the procedure. Blood sample once collected is then sent to the laboratory.
Q. Is there any risk associated with this test?
There is no risk associated with the test. However, as this test involves a needle prick to withdraw the blood sample, rarely, a patient may experience increased bleeding, hematoma (blood collection under the skin) formation, bruising or infection at the site of needle prick.
+ more

Provided By

NABL

CAP

ISO

With a decade of experience under its belt, Oncquest is known for its excellence in Clinical Diagnostics. From its first avatar as an R&D focused entity, Oncquest has evolved into a reference laboratory in the field of Oncology, and more recently into a multi-platform Pathology Services provider with a core focus in Molecular Pathology and Surgical Pathology Services. Its logistic capabilities and geographical spread makes Oncquest an ideal associate for clinical activities in India. Oncquest’s accredited quality systems ensure customer satisfaction through any of its customer-centric service offerings. Oncquest’s recent advances in the areas of Companion Diagnostics and Pharmacogenomics have also allowed for and encouraged greater penetration of Personalized Medicine into the Indian healthcare market, making it the future epicentre of the many technological advancements in healthcare, to come. Its close association with many Hospitals across India stands testament to the faith that Oncquest has instilled in the doctors and patients which avail of its services. Oncquest is fast becoming a cornerstone for a blooming healthcare industry. With over a decade of experience in the field of molecular diagnostics and pathology services, Oncquest Laboratories has earned its reputation of clinical excellence in the Indian market. Our advanced technologies and global quality systems have ensured that we stay ahead of the curve, and this has resulted in our association with some of the most advanced clinicians, hospitals and research organizations in the country. As India gets set for a clinical revolution, ushering in a trend of new healthcare services and products, Oncquest has defined its place as a partner of choice for those who bring value to our proud subcontinent. Our national reach and sizeable knowledge base allows us to be at the forefront of scientific advances, and an ideal partner for clinical activities. We strive to be connected with the best in the industry and we welcome partnership in ideas and technologies. For example, Oncquest’s early adoption and utilization of genetic sequencing technologies has resulted in many “first to market” assays, which have subsequently been adopted in several treatment and monitoring protocols. Innovation is an essential part of our DNA. We welcome challenges, and look forward to associating with you and your organizations to develop pioneering solutions and to tackle some of the most pressing issues faced in our world.

Available at Other Labs

VIEW ALL